Home › Calculator › CTNM Dividend Calculator 2026
CTNM Dividend DRIP Calculator 2026
14.22% YieldHealthcareContineum Therapeutics, Inc. · NASDAQ
Price: $14.06 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CTNM pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your CTNM snowball 📈
$10,000 in CTNM → $37.8K in 10 years · $392.38/month
About Contineum Therapeutics, Inc. (CTNM) — Dividend Analysis 2026
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States. The company’s lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and chronic pain. It also develops PIPE-307, a novel, small-molecule inhibitor of the muscarinic type 1 receptor for depression and relapse-remitting multiple sclerosis. The company was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. Contineum Therapeutics, Inc. was incorporated in 2009 and is based in San Diego, California.
Compare CTNM with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CTNM DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CTNM position with:
🌍 CTNM Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CTNM.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 14.22% | 11.42% | $1,422 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 12.09% | 9.29% | $1,209 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 11.38% | 8.58% | $1,138 / yr |
| 🇬🇧 UK ISA | 0% | 14.22% | 11.42% | $1,422 / yr |
| 🇬🇧 UK Taxable | 8.75% | 12.98% | 10.18% | $1,298 / yr |
| 🇨🇦 TFSA | 0% | 14.22% | 11.42% | $1,422 / yr |
| 🇨🇦 CA Taxable | 25% | 10.67% | 7.87% | $1,067 / yr |
| 🇦🇺 Super (pension) | 15% | 12.09% | 9.29% | $1,209 / yr |
| 🇦🇺 AU Taxable | 30% | 9.95% | 7.15% | $995 / yr |
| 🇩🇪 DE Taxable | 26.375% | 10.47% | 7.67% | $1,047 / yr |
| 🇫🇷 FR Taxable | 30% | 9.95% | 7.15% | $995 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CTNM Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CTNM Dividend Payment Schedule
CTNM pays quarterly — 4 times per year. Next ex-div: TBD.
📊 CTNM vs Healthcare Benchmarks
How CTNM compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CTNM sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CTNM Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-07-08 | 1,015 | $1.01 | $1.0K | ||
| M-Exempt | 2026-07-09 | 25 | $1.01 | $25.00 | ||
| Sale | 2026-07-09 | 25 | $16.00 | $400.00 | ||
| M-Exempt | 2026-07-08 | 1,015 | $1.01 | $1.0K | ||
| M-Exempt | 2026-07-09 | 25 | $1.01 | $25.00 | ||
| M-Exempt | 2026-07-08 | 2,500 | $1.01 | $2.5K | ||
| M-Exempt | 2026-07-08 | 2,500 | $1.01 | $2.5K | ||
| Sale | 2026-07-08 | 2,500 | $16.00 | $40.0K | ||
| M-Exempt | 2026-06-30 | 28,826 | $1.01 | $29.1K | ||
| M-Exempt | 2026-07-01 | 4,183 | $1.01 | $4.2K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CTNM dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Contineum Therapeutics, Inc. (CTNM) is currently trading at $14.06, 33% below its 52-week high. The current dividend yield is 14.22% based on an annual payout of $2.00 per share.
CTNM (Contineum Therapeutics, Inc.) — 14.22% Dividend Yield Analysis
Contineum Therapeutics, Inc. (CTNM) is a healthcare stock currently trading at $14.06 with a dividend yield of 14.22%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (14.22%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.